Polyethylene Glycol (PEG) linkers are essential components in advancing biotherapeutics and diagnostics, valued for enhancing solubility, stability, and reducing immunogenicity in applications such as antibody-drug conjugates (ADCs) and PEGylated proteins. This guide outlines key selection criteria—from functional group compatibility to application-specific needs—to support researchers in optimizing linker choice for projects including ADC development, protein conjugation, and diagnostic assays, enabling informed decisions and accelerated progress.

1. Understanding the Core Components of a PEG Linker
Structurally, a PEG linker features two reactive functional groups connected by a PEG spacer. The spacer length modulates physicochemical properties, while the functional groups, which are different in heterobifunctional types, enable sequential conjugation to two distinct molecules like an antibody and a drug payload.
Image: The fundamental structure of a heterobifunctional PEG linker.
2. Define Your Application
You need to clarify your end goalto help determine subsequent choices.
- Drug Delivery: Are you creating an ADC to deliver a cytotoxic payload to a tumor?
- Protein Modification: Are you PEGylating a therapeutic protein to extend its half-life?
- Diagnostics: Are you attaching a fluorescent dye to an antibody for an imaging assay?
- Surface Modification: Are you coating a nanoparticle or medical device?
3. Choose Your Functional Groups
Your choice of functional groups depends on the available reactive sites on your molecules of interest (e.g., proteins, antibodies, small molecule drugs).
Common Amine-Reactive Groups
Amines (-NH₂) are abundant on proteins (lysine residues) and are a common target for conjugation.
- NHS Esters (N-Hydroxysuccinimide): Highly popular for their efficiency in reacting with primary amines at neutral to slightly alkaline pH. They form stable amide bonds.
Explore our PEGylation Reagents featuring NHS esters.
Common Thiol-Reactive Groups
Thiols (-SH) from cysteine residues offer more specific and controlled conjugation sites, as they are less common than amines.
- Maleimides: React very specifically with thiols at a neutral pH to form a stable thioether bond. This is a go-to reaction for site-specific antibody conjugation.
- Disulfides (e.g., SPDP): React with thiols to form a disulfide bond. This bond is cleavable in a reducing environment, making it useful for drug release inside cells.
Click Chemistry Groups
Click chemistry provides highly efficient, specific, and biocompatible reactions that proceed quickly without side products.
- Azides (N₃) and Alkynes (e.g., DBCO, BCN): Azides react with terminal alkynes (CuAAC reaction) or strained cyclooctynes like DBCO and BCN (copper-free SPAAC reaction). These are ideal for complex multi-step conjugations.
Find the perfect pairing in our Clickable Linkers catalog.
Other Reactive Groups
- Aldehydes: React with hydrazides or aminooxy groups.
- Carboxylic Acids (-COOH): Can be activated with EDC to react with primary amines.
Click the link PurePEG Offical Site – PurePEG to select additional functional groups.
4. Selection of Cleavable and Non-Cleavable Linkers
Cleavable Linkers
Cleavable linkers are designed to release payloads in response to specific biological triggers. They are ideal for: activating free-form payloads; enabling bystander effects against neighboring cells; and achieving site-specific prodrug activation.
Common cleavable linkers include enzyme-sensitive types with peptide substrates (e.g., Val-Cit) for cleavage by tumor-associated enzymes like cathepsin B; pH-sensitive linkers (e.g., hydrazone) that break in the acidic environment of endosomes/lysosomes; and redox-sensitive disulfide linkers, which are cleaved in the highly reducing intracellular milieu.
Find linkers for your cleavable PEG linker synthesis in our dedicated Cleavable Linkers category.
Non-Cleavable Linkers
Non-cleavable linkers form a permanent, stable bond, releasing the payload only after the entire antibody or protein carrier is degraded within the lysosome. This makes them ideal for applications requiring maximum plasma stability, minimizing off-target toxicity from premature release, or when the resulting drug-linker-amino acid metabolite retains potent activity.
For stable constructs, explore our Heterobifunctional PEG Linkers.
Featured Products
5. Select the Right PEG Chain Length
The length of the PEG chain will have the following effects:
- Solubility: Longer PEG chains significantly increase the water solubility of hydrophobic molecules.
- Steric Hindrance: A longer chain can help overcome steric hindrance, ensuring that large molecules (like antibodies) can bind to their targets without interference from the payload.
- Pharmacokinetics: Longer chains increase the hydrodynamic size of the conjugate, which can reduce kidney clearance and extend circulation half-life.
- Immunogenicity: The PEG chain can “mask” the conjugated molecule from the immune system.
PurePEG offers a wide variety of PEG chain lengths, from short (PEG4) to very long (PEG45), all with monodispersity for consistent results.
6. Application-Specific Recommendations
| Application | Key Considerations | Recommended Linker Type |
| Antibody-Drug Conjugates (ADCs) | Hydrophilicity and Aggregation Propensity; Drug Release Mechanism at the Target Site; Drug-to-Antibody Ratio (DAR); Conjugation Chemistry and Functional Groups. | Cleavable Linkers;Heterobifunctional PEGs |
| Protein/Peptide Conjugation | Improving Solubility and Stability; Preserving Biological Activity; Reducing Immunogenicity; Controlling the Degree of Modification and Homogeneity. | Homobifunctional PEGs; Heterobifunctional PEG; PEG45; Clickable Linkers; Multi-Arm PEGs; PEGylation Reagents |
| Diagnostics & Imaging | Enhancing water solubility and stability; Optimizing in vivo distribution and elimination; Maintaining the activity of recognition units;Simplifying the conjugation process. | Biotinylation Reagents; Clickable Linkers; Heterobifunctional PEG ; Cleavable Linkers |
| PROTACs | Formation of ternary complexes; Regulation of hydrophilicity; Linkage sites and steric hindrance; Balance between length and degradation activity. | PROTAC; Clickable Linkers
|
| LNP Formulation (e.g., mRNA) | Modulating PEG shedding kinetics; Enhancing colloidal stability; Influencing liver tropism; Avoiding immunogenicity. | PEG-Lipid |
7. Conclusion: Making the Right Choice with PurePEG
Choosing the right PEG linker involves a careful balance of chemistry, biology, and application-specific goals. By systematically considering your target molecules, desired release mechanism, and overall objectives, you can navigate the selection process with confidence.
At PurePEG, our mission is to provide you with the highest quality, monodisperse PEG linkers to ensure your research is reproducible, reliable, and revolutionary. Our expert team is always available to help you select the perfect linker for your project.

